Chemed Corp
(NYSE:CHE)
$
558.27
3.55 (0.64%)
Market Cap: 8.36 Bil
Enterprise Value: 8.22 Bil
PE Ratio: 28.21
PB Ratio: 6.77
GF Score: 95/100 Chemed Corp at Oppenheimer Healthcare Conference (Virtual) Transcript
Mar 14, 2023 / 05:20PM GMT
Release Date Price:
$516
(+2.07%)
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Good afternoon. Welcome to Oppenheimer's 33rd Annual Healthcare Conference. I'm Mike Wiederhorn, the healthcare services analyst. It's my pleasure to have Chemed Corporation today. We have President and CEO, Kevin McNamara; and Chief Financial Officer, David Williams. This is going to be fireside. Welcome, guys. Thanks for joining us today.
David P. Williams
Chemed Corporation - Executive VP & CFO
Thanks, Mike.
Questions & Answers
Michael David Wiederhorn
Oppenheimer & Co. Inc., Research Division - MD & Senior Analyst
Thank you. I'll start off with a general question. Can you just kind of give us your thoughts around now that you're a few months into 2023 under your belt, how should we view trends in the business? And do you think we can use this year as a normalized base to grow off of?
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot